Search company, investor...
LifeSpan BioSciences company logo

LifeSpan BioSciences

Founded Year



Acq - Fin | Alive

Total Raised


About LifeSpan BioSciences

LifeSpan BioSciences provides antibodies, proteins, biochemicals, ELISA and Assay Kits, immunohistochemistry data and services to researchers.

Headquarters Location

2401 Fourth Avenue Suite 900

Seattle, Washington, 98121,

United States


Missing: LifeSpan BioSciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: LifeSpan BioSciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

LifeSpan BioSciences Patents

LifeSpan BioSciences has filed 4 patents.

patents chart

Application Date

Grant Date


Related Topics




Digestive system, Dosage forms, Drug delivery devices, Muscarinic antagonists, Calcium channel blockers


Application Date


Grant Date



Related Topics

Digestive system, Dosage forms, Drug delivery devices, Muscarinic antagonists, Calcium channel blockers



Latest LifeSpan BioSciences News

Glycated Albumin Assay Market size to reach USD 776.5 Million by 2028 | Asahi Kasei, Diazyme Lab, LifeSpan Bio

Nov 16, 2022

| Asahi Kasei, Diazyme Lab, LifeSpan Bio News Provided By Share This Article Glycated Albumin Assay Market SEATTLE, UNITED STATES, UNITED STATES, November 16, 2022 / / -- ????The Glycated Albumin Assay market is estimated to be valued at US$ 776.5 million in 2028 and is expected to exhibit a CAGR of 7.7% over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Glycated albumin assay is the amount of a marker directly connected to many serious side-effects of diabetes. It has been exhibited to be a better reflection of the efficiency of therapeutics compared to other trials. It has currently been presented to be an efficient marker to screen for mellitus at an initial stage. Competitive Landscape: Major players included in the global glycated albumin assay market are Geno Technology, Inc., DRG International, Inc., Asahi Kasei Corporation, LifeSpan BioSciences, Inc., Abbexa Ltd.,DxGen Corp., Diazyme Laboratories, Inc., AMS Biotechnology (Europe) Limited, Abnova Corporation, Biomatik Corporation, Ethos Biosciences, Inc., Epinex Diagnostics Inc., and PathShodh Healthcare Private Limited. Get Sample Report of Glycated Albumin Assay Market Report: Key Market Drivers: The increasing number of diabetes cases is expected to boost the growth of the global glycated albumin assay market. As per IDF.Org, around 537 million adults’ ages between 20 years to 80 years are suffering from diabetes in the year 2021 across the globe. Rising approval of inorganic growth plans such as collaborations and acquisitions by market players is projected to propel growth of the global glycated albumin assay market. For example, in July 2018, Asahi Kasei Corporation signed a MoU with Stanbio Laboratory, L.P for promoting of Lucica GA-L in the U.S. Covid-19 Impact Analysis: The Covid-19 outbreak had led to an adverse impact on the growth of global Glycated Albumin Assay market due to the strict imposition of shut down and lockdown by the regulatory and moreover, the spread of virus had led to the restrictions in movement of people from one place to other and also visits to the hospitals for regular check-up had led to the decline in market growth. ⏩ Glycated Albumin Assay Market Segmentation: By Product Type: 2] Who are the potential customers of the Glycated Albumin Assay Market? 3] How can I get a report sample of the Glycated Albumin Assay Market? 4] What are the key trends in Glycated Albumin Assay Market? 5] Who are the leading players in Glycated Albumin Assay Market? 6] How can I get statistical data on the top market players in the Glycated Albumin Assay Market? 7] Which segment holds the maximum share of the Glycated Albumin Assay Market? 8] What is the total market value of the Glycated Albumin Assay Market? 9] What is the CAGR of the Glycated Albumin Assay Market? Purchase this report (Up to 40% Discount):

LifeSpan BioSciences Frequently Asked Questions (FAQ)

  • When was LifeSpan BioSciences founded?

    LifeSpan BioSciences was founded in 1995.

  • Where is LifeSpan BioSciences's headquarters?

    LifeSpan BioSciences's headquarters is located at 2401 Fourth Avenue, Seattle.

  • What is LifeSpan BioSciences's latest funding round?

    LifeSpan BioSciences's latest funding round is Acq - Fin.

  • How much did LifeSpan BioSciences raise?

    LifeSpan BioSciences raised a total of $32.2M.

  • Who are the investors of LifeSpan BioSciences?

    Investors of LifeSpan BioSciences include Thompson Street Capital Partners, SAIC, Equity4Life, LODH Private Equity Partners and Forstmann Asset Management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.